Is Alexander's (ALX) Outperforming Other Finance Stocks This Year?
Here is how Alexander's (ALX) and Healthpeak (DOC) have performed compared to their sector so far this year.
Best Momentum Stocks to Buy for August 11th
DINO, QUAD and ALX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 11, 2026.
New Strong Buy Stocks for August 11th
ALX, DINO, OPBK, CYD and HLLY have been added to the Zacks Rank #1 (Strong Buy) List on August 11, 2026.
Best Income Stocks to Buy for August 11th
ALX, SHIP and QUAD made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 11, 2026.
Alexander's (ALX) Upgraded to Strong Buy: Here's Why
Alexander's (ALX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Alexander's Q2 Earnings Call Highlights
Vornado Realty Trust reported second-quarter comparable funds from operations of $0.67 per share, up from $0.56 a year earlier, as leasing gains at its PENN District properties, signage revenue and New York office and retail performance contributed to growth.
Alexander's (ALX) Beats Q2 FFO and Revenue Estimates
Alexander's (ALX) came out with quarterly funds from operations (FFO) of $3.02 per share, beating the Zacks Consensus Estimate of $3 per share. This compares to FFO of $2.88 per share a year ago.
The Most Hated High Yields On Wall Street
Let's capitalize on analyst incompetence—and bank yields up to 18.3%, with upside to boot!
ALX Oncology Q1 Earnings Call Highlights
ALX Oncology NASDAQ: ALXO executives used the company's first-quarter 2026 earnings call to highlight new clinical data for its lead CD47 blocker, evorpacept, and to provide updates on its EGFR-targeted antibody-drug conjugate program, ALX2004. CEO Jason Lettmann said the quarter featured “continued good execution,” including a February financing and the addition of Jeff Knight as chief development and chief operating officer.
Alexander's (ALX) Q1 FFO and Revenues Lag Estimates
Alexander's (ALX) came out with quarterly funds from operations (FFO) of $2.6 per share, missing the Zacks Consensus Estimate of $3.08 per share. This compares to FFO of $4.06 per share a year ago.
Alexander’s (NYSE:ALX) Shares Pass Above 200 Day Moving Average – Should You Sell?
Alexander's, Inc. (NYSE: ALX - Get Free Report) shares crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $230.09 and traded as high as $251.00. Alexander's shares last traded at $244.4490, with a volume of 69,183 shares changing hands. Analyst Ratings Changes A number of analysts
Are Finance Stocks Lagging Alexander's (ALX) This Year?
Here is how Alexander's (ALX) and Northern Trust Corporation (NTRS) have performed compared to their sector so far this year.
